Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general Practice
The LancetPublished 1 January 2001
Maria Carla Roncaglioni
Citations996
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
In women and men at risk of having a cardiovascular event because of the presence of at least one major risk factor, low-dose aspirin given in addition to treatment of specific risk factors contributes an additional preventive effect, with an acceptable safety profile.
Abstract
In women and men at risk of having a cardiovascular event because of the presence of at least one major risk factor, low-dose aspirin given in addition to treatment of specific risk factors contributes an additional preventive effect, with an acceptable safety profile. The results on vitamin E's cardiovascular primary preventive efficacy are not conclusive per se, although our results are consistent with the negative results of other large published trials on secondary prevention.
Keywords
Medicine
Journal of the Royal Statistical Society Series B (Statistical Methodology)Regression Models and Life-Tables
39,259 Citations1972D. R. Cox
The LancetA randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
6,453 Citations1996
Long-term administration of clopidogrel to patients with atherosclerotic vascular disease is more effective than aspirin in reducing the combined risk of ischaemic stroke, myocardial infarction, or vascular death.
The LancetEffects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
5,765 Citations1998Lennart Hansson, Alberto Zanchetti +8 more
Intensive lowering of blood pressure in patients with hypertension was associated with a low rate of cardiovascular events and the potential benefit of a low dose of acetylsalicylic acid in the treatment of hypertension was assessed.
The LancetDietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial
3,803 Citations1999
Dietary supplementation with n-3 PUFA led to a clinically important and statistically significant benefit and vitamin E had no benefit and its effects on fatal cardiovascular events require further exploration.
New England Journal of MedicineVitamin E Consumption and the Risk of Coronary Heart Disease in Men
2,355 Citations1993Eric B. Rimm, Meir J. Stampfer +4 more
Evidence is provided of an association between a high intake of vitamin E and a lower risk of coronary heart disease in men, and public policy recommendations with regard to the use ofitamin E supplements should await the results of additional studies.
New England Journal of MedicineFinal Report on the Aspirin Component of the Ongoing Physicians' Health Study
2,254 Citations1989Steering Committee of the Physicians' Health Study Research Group
This trial of aspirin for the primary prevention of cardiovascular disease demonstrates a conclusive reduction in the risk of myocardial infarction, but the evidence concerning stroke and total cardiovascular deaths remains inconclusive because of the inadequate numbers of physicians with these end points.
The LancetRandomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
2,153 Citations1996Nigel Stephens, A Parsons +5 more
It is concluded that in patients with angiographically proven symptomatic coronary atherosclerosis, alpha-tocopherol treatment substantially reduces the rate of non-fatal MI, with beneficial effects apparent after 1 year of treatment.
New England Journal of MedicineVitamin E Consumption and the Risk of Coronary Disease in Women
2,111 Citations1993Meir J. Stampfer, Charles H. Hennekens +4 more
New England Journal of MedicineVitamin E Supplementation and Cardiovascular Events in High-Risk Patients
1,956 Citations2000The Heart Outcomes Prevention Evaluation Study Investigators
In patients at high risk for cardiovascular events, treatment with vitamin E for a mean of 4.5 years had no apparent effect on cardiovascular outcomes and there were no significant differences in the incidence of secondary cardiovascular outcomes or in death from any cause.
AtherosclerosisPrevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
1,264 Citations1998David Wood, Guy De Backer +4 more
The Task Force has summarized the most important clinical issues on coronary heart disease prevention on which there is good agreement in order to give cardiologists and physicians, and other health care professionals, the best possible advice to facilitate their work on coronaryHeart disease prevention.
BMJRandomised trial of prophylactic daily aspirin in British male doctors
1,162 Citations1988Richard Peto, Richard Gray +10 more
A six year randomised trial was conducted among 5139 apparently healthy male doctors to see whether 500 mg aspirin daily would reduce the incidence of and mortality from stroke, myocardial infarction, or other vascular conditions.
European Heart JournalPrevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
1,126 Citations1998Second Joint Task Force of European
The LancetThrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
789 Citations1998
Combined treatment with warfarin and aspirin is more effective in the reduction of IHD than either agent on its own.
TechnometricsAnalysing Survival Data From Clinical Trials and Observational Studies
664 Citations1996
The LancetThe antioxidant paradox
644 Citations2000Barry Halliwell
Intakes of vitamin C below the recommended daily allowance are associated with increased free-radical damage to DNA 4,11 but, paradoxically, so is supplementation with high-dose vitamin C.
BMJDetermination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial
119 Citations2000T W Meade, P J Brennan
The evidence suggests that the benefit of low dose aspirin in primary prevention may occur mainly in those with lower systolic blood pressures, although it is not clear even in these men that the benefits outweighs the potential hazards.
The LancetApplication of evidence from randomised controlled trials to general practice
95 Citations1999Walter Rosser
BMJRandomised controlled trials in general practice
74 Citations1995Mike Pringle, Dick Churchill
The particular problems of recruitment and randomisation merit consideration with respect to primary care, and applying experimental methods in clinical practice presents problems that, if not properly addressed or acknowledged, may invalidate the findings.
Cerebrovascular DiseasesTelephone Interview for Stroke Outcome Assessment
64 Citations1994L. Candelise, G. Pinardi +2 more
Two groups of stroke patients were evaluated in order to test the reliability of telephone assessment of stroke disability with the modified Rankin scale.
Archives of Internal MedicineThe Long-term Prognostic Significance of Repeated Blood Pressure Measurements in the Elderly
55 Citations1999C Alli
It is suggested that SBP, but not DBP, is a strong, positive, continuous, independent indicator of mortality risk in the elderly and should be stressed much more than DBP in the diagnosis and treatment of hypertension in this age group.
PubMedApplying the results of clinical trials to patients to general practice: perceived problems, strengths, assumptions, and challenges for the future.
49 Citations1998Tom Fahey
This paper aims to outline the perceived barriers against the use of RCTs in practice, while emphasizing the rationale and advantages underlying the approach.
The LancetDo vitamin E and fish oil protect against ischaemic heart disease?
36 Citations1999Matthew A. Brown
PubMedFeasibility of a long-term low-sodium diet in mild hypertension.
30 Citations1992C Alli, Fausto Avanzini +8 more
The data suggest that it is not feasible at present to reduce sodium intake in mild hypertensives with simple and inexpensive dietary instructions, the only ones suitable for widespread application in general practice.
Statistics in MedicineThe case of gissi in changing the attitudes and practice of Italian cardiologists
22 Citations1990Gianni Tognoni, Maria Grazia Franzosi +5 more
The efficiency achieved by a large scale clinical trial (GISSI) is described and how a comprehensive research project based upon an innovative clinical trial methodology can influence the attitude and the scientific productivity of a professional community operating within a national health system is emphasized.
BMJFeasibility of a large prospective study in general practice: an Italian experience. Gruppo di Studio sulla Pressione Arteriosa nell'Anziano.
13 Citations1987Fausto Avanzini, C Alli +8 more
The creation of networks of general practitioners who are prepared to carry out research in their practices would allow treatment and preventive measures to be studied simply and at low cost in the appropriate setting.
The LancetCould institutional clinical trials exist in Europe?
9 Citations1999Catherine Cornu, Antonio Cano +3 more
ScienceFinancial Interests Constrain Drug Development
8 Citations1997Silvio Garattini
The disparity between patients' needs and the interests of industry can be further illustrated by the problem of resistance, which shows that the approach to developing and evaluating drugs needs to change, in order to reduce the discrepancy of interest between industry and the ill.
Journal of Cardiovascular RiskEpidemiological feasibility of cardiovascular primary prevention in general practice: a trial of vitamin E and aspirin
7 Citations1995
The LancetTreatment of hypertension in elderly patients
3 Citations1997Caroline Nabel, Frank Schweda +2 more
The LancetTreatment of hypertension in elderly patients
1 Citations1997Fausto Avanzini, Claudio Alii +1 more